Modelling patterns of clearance of HPV-16 infection and vaccination efficacy
- 1 February 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 29 (6), 1270-1277
- https://doi.org/10.1016/j.vaccine.2010.11.082
Abstract
No abstract availableKeywords
Funding Information
- Sanofi Pasteur MSD
- Merck
- GSK
This publication has 33 references indexed in Scilit:
- HPV-16 infection and cervical cancer: Modeling the influence of duration of infection and precancerous lesionsEpidemics, 2010
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenThe Lancet, 2009
- Prophylactic Efficacy of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Women with Virological Evidence of HPV InfectionThe Journal of Infectious Diseases, 2007
- The Natural History of Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia Among Young Women in the Guanacaste Cohort Shortly After Initiation of Sexual LifeSexually Transmitted Diseases, 2007
- Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled TrialJNCI Journal of the National Cancer Institute, 2006
- Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling AnalysesPLoS Medicine, 2006
- Cell-Mediated Immune Response to Human Papillomavirus InfectionClinical and Diagnostic Laboratory Immunology, 2001
- Epidemiology and Control of Curable Sexually Transmitted DiseasesSexually Transmitted Diseases, 2000
- Comparison of Human Papillomavirus Types 16, 18, and 6 Capsid Antibody Responses Following Incident InfectionThe Journal of Infectious Diseases, 2000
- Social Desirability Bias in Dietary Self-Report May Compromise the Validity of Dietary Intake MeasuresInternational Journal of Epidemiology, 1995